Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where George W. Keilman is active.

Publication


Featured researches published by George W. Keilman.


Journal of the Acoustical Society of America | 2004

Ultrasound therapy head configured to couple to an ultrasound imaging probe to facilitate contemporaneous imaging using low intensity ultrasound and treatment using high intensity focused ultrasound

Shahram Vaezy; Roy W. Martin; Stephen J. Carter; George W. Keilman; Victor Y. Fujimoto; Lawrence A. Crum

Method and apparatus for the simultaneous use of ultrasound on a probe for imaging and therapeutic purposes. The probe limits the effects of undesirable interference noise in a display by synchronizing high intensity focused ultrasound (HIFU) waves with an imaging transducer to cause the noise to be displayed in an area of the image that does not overlap the treatment site. In one embodiment, the HIFU is first energized at a low power level that does not cause tissue damage, so that the focal point of the HIFU can be identified by a change in the echogenicity of the tissue caused by the HIFU. Once the focal point is properly targeted on a desired treatment site, the power level is increased to a therapeutic level. The location of each treatment site is stored and displayed to the user to enable a plurality of spaced-apart treatment sites to be achieved. As the treatment progresses, any changes in the treatment site can be seen in the real time, noise-free image. A preferred application of the HIFU waves is to cause lesions in blood vessels, so that the supply of nutrients and oxygen to a region, such as a tumor, is interrupted. The tumor will thus eventually be destroyed. In a preferred embodiment, the HIFU is used to treat disorders of the female reproductive system, such as uterine fibroids. The HIFU treatment can be repeated at spaced-apart intervals, until any remaining fibroid tissue is destroyed.


Ultrasound in Medicine and Biology | 1998

Hemostasis of punctured blood vessels using high-intensity focused ultrasound

Shahram Vaezy; Roy W. Martin; Hadi Yaziji; Peter J. Kaczkowski; George W. Keilman; Steve Carter; Michael T. Caps; Emil Y. Chi; Michael R. Bailey; Lawrence A. Crum

The hemorrhagic complications of vascular injury can be significant. We report on the use of high-intensity focused ultrasound (HIFU) to stop the hemorrhage of punctured blood vessels in pigs. Two HIFU transducers with frequencies of 3.5 and 2.0 MHz, each equipped with a water-filled conical housing, were used. Major blood vessels (femoral artery and vein, axillary artery, carotid artery and jugular vein), 2-10 mm in diameter, of anesthetized pigs were exposed surgically and punctured with 14- and 18-gauge needles to produce moderate to profuse bleeding. Complete hemostasis was achieved in less than 3 min of HIFU treatment in most blood vessels, and all vessels were patent after the treatment. Both HIFU frequencies were effective in producing hemostasis. Gross examination of the HIFU-treated vessels showed a consistent hardening of the soft tissue surrounding the blood vessels, providing a seal for the puncture hole. Microscopic examination of the vessels showed a remarkably localized HIFU treatment, resulting in coagulation of the adventitia, and an extensive fibrin network around the vessels and in the puncture hole. The vessel walls exhibited focal swelling, without evidence of irreversible injury. HIFU may provide a useful method for achieving hemostasis of punctured and traumatized blood vessels in a variety of clinical settings.


Ultrasound in Medicine and Biology | 1999

Effect of high-intensity focused ultrasound on whole blood with and without microbubble contrast agent

Sandra L. Poliachik; Wayne L. Chandler; Pierre D. Mourad; Michael R. Bailey; Susannah H. Bloch; Robin O. Cleveland; Peter J. Kaczkowski; George W. Keilman; Tyrone M. Porter; Lawrence A. Crum

Using human whole blood samples with and without contrast agent (CA), we evaluated the effect of exposures to focused, continuous wave (CW) 1.1-MHz ultrasound for durations of 10 ms to 1 s at spatial average intensities of 560 to 2360 W/cm2. Cavitation was monitored with a passive cavitation detector and hemolysis was determined with spectroscopy. In whole blood alone, no significant cavitation, heating or hemolysis was detected at any exposure condition. Conversely, cavitation and hemolysis, but not heating, were detected in whole blood with CA. A CA concentration as low as 0.28 microL CA per mL whole blood at an intensity of 2360 W/cm2 for 1 s resulted in measurable cavitation and a 6-fold increase in hemolysis compared to shams. Cavitation and hemolysis increased proportional to the concentration of CA and duration of exposure. In samples containing 4.2 microL CA per mL whole blood exposed for 1 s, a threshold was seen at 1750 W/cm2 where cavitation and hemolysis increased 10-fold compared to exposures at lower intensities. HIFU exposure of whole blood containing CA leads to significant hemolysis in vitro and may lead to clinically significant hemolysis in vivo.


Journal of Vascular Surgery | 1999

Use of high-intensity focused ultrasound to control bleeding

Shahram Vaezy; Roy W. Martin; Peter J. Kaczkowski; George W. Keilman; Bryan Goldman; Hadi Yaziji; Steve Carter; Michael T. Caps; Lawrence A. Crum

OBJECTIVE High-intensity focused ultrasound (HIFU) has been shown to be effective in controlling hemorrhage from punctures in blood vessels. The objective of the current study was to investigate the capability of HIFU to stop bleeding after a more severe type of vascular injury, namely longitudinal incisions of arteries and veins. METHODS The superficial femoral arteries, common femoral arteries, carotid arteries, and jugular veins of four anesthetized pigs were exposed surgically. A longitudinal incision, 2 to 8 mm in length, was produced in the vessel. HIFU treatment was applied within 5 seconds of the onset of the bleeding. The HIFU probe consisted of a high-power, 3.5-MHz, piezoelectric transducer with an ellipsoidal focal spot that was 1 mm in cross section and 9 mm in axial dimension. The entire incision area was scanned with the HIFU beam at a rate of 15 to 25 times/second and a linear displacement of 5 to 10 mm. A total of 76 incisions and HIFU treatments were performed. RESULTS Control of bleeding (major hemosatsis) was achieved in all 76 treatments, with complete hemostasis achieved in 69 treatments (91%). The average treatment times of major and complete hemostasis were 17 and 25 seconds, respectively. After the treatment, 74% of the vessels in which complete hemostasis was achieved were patent with distal blood flow and 26% were occluded. The HIFU-treated vessels showed a consistent coagulation of the adventitia surrounding the vessels, with a remarkably localized injury to the vessel wall. Extensive fibrin deposition at the treatment site was observed. CONCLUSION HIFU may provide a useful method of achieving hemostasis for arteries and veins in a variety of clinical applications.


Ultrasound in Medicine and Biology | 1999

Hemostasis of punctured vessels using Doppler-guided high-intensity ultrasound.

Roy W. Martin; Shahram Vaezy; Peter J. Kaczkowski; George W. Keilman; Steve Carter; Michael T. Caps; Kirk W. Beach; Melani Plett; Lawrence A. Crum

The use of Doppler ultrasound was investigated to determine if it would aid in guiding the application of high-intensity focused ultrasound (HIFU) to stop bleeding from punctured vessels. Major vessels (abdominal aorta, illiac, carotid, common femoral and superficial femoral arteries and the jugular vein) were surgically exposed, punctured and treated in anesthetized pigs. Treatment was applied when the Doppler sounds indicated the focus coincided with the bleeding site. In 89 treatment trials, the average time to achieve major hemostasis (a point where bleeding was reduced to a level of only oozing) was 8 s, and for complete hemostasis was 13 s. These times were significantly shorter than those of an identical former study in which only visual guidance was used. In that study, the average times for major and complete hemostasis were 40 and 62 s, respectively. The advantage of Doppler guidance in applying HIFU in treating bleeding vessels was demonstrated.


Journal of Trauma-injury Infection and Critical Care | 1999

Control of splenic bleeding by using high intensity ultrasound.

Shahram Vaezy; Roy W. Martin; George W. Keilman; Peter J. Kaczkowski; Emil Y. Chi; Eskandar Yazaji; Michael T. Caps; Sandra L. Poliachik; Steve Carter; Sam R. Sharar; Carol Cornejo; Lawrence A. Crum

BACKGROUND High-intensity focused ultrasound (HIFU) has been shown to control bleeding from liver incisions, and blood vessel punctures and incisions. The objective of the current study was to investigate the capability of HIFU to stop bleeding from splenic injuries in a pig model. METHODS Surgical incisions, 25 to 50 mm in length and 2 to 8 mm in depth, were made in the spleens of five anesthetized pigs. HIFU with a frequency of 5 MHz was applied within 5 seconds of making the incision. A total of 39 incisions and HIFU treatments were performed. RESULTS Bleeding from all incisions was stopped completely after HIFU treatment. The average times to control and completely arrest the hemorrhage were 28 and 55 seconds, respectively. The mechanisms of hemostasis appeared to be thermally induced coagulation necrosis of splenic tissue and occlusion of blood vessels by a mechanically induced homogenized splenic tissue. CONCLUSION HIFU may provide a useful method of hemostasis for actively bleeding spleen. Because of its ability to induce hemostasis at adjustable depth, HIFU may prove to be a useful cauterization method both in the operating room and for patients who are managed nonoperatively.


Journal of Ultrasound in Medicine | 2001

Attenuation Coefficient and Sound Speed in Human Myometrium and Uterine Fibroid Tumors

Amid Keshavarzi; Shahram Vaezy; Peter J. Kaczkowski; George W. Keilman; Roy W. Martin; Emil Y. Chi; Rochelle L. Garcia; Victor Y. Fujimoto

To develop a noninvasive method for treatment of uterine fibroid tumors using high‐intensity focused ultrasound. Optimal high‐intensity focused ultrasound treatment would be dependent on quantitative information about ultrasonic tissue characteristics.


Journal of the Acoustical Society of America | 2002

Ultrasonic sensors for monitoring the condition of flow through a cardiac valve

George E. Cimochowski; George W. Keilman

A parameter indicative of the condition of a cardiac valve is determined by monitoring blood flow and/or velocity in a vessel that is coupled to the cardiac valve or in a chamber adjacent to an artificial cardiac valve. One or more ultrasonic transducers are provided either in a wall or a cuff disposed about a cardiac vessel to monitor the parameter in regard to a natural or artificial cardiac valve, or in a support sewing ring of an artificial cardiac valve. A conformal array transducer or a tilted element is used to monitor fluid flow or velocity based on the effect of the blood on ultrasonic waves produced by the transducers. The conformal array transducer comprises a plurality of elements that are excited with an input signal provided by an implantable electronics circuit, producing ultrasonic waves. Transit time or Doppler measurements are made using an appropriate number of these transducers to determine either blood volumetric flow or velocity. Various implantable electronic circuits are disclosed that enable a transducer to be driven and to receive an ultrasonic signal indicative of the status of blood flow and thus, the condition of the cardiac valve. A radio frequency (RF) coil is coupled to an external coil. The external coil is connected to a power supply and monitoring console, conveying power to the ultrasonic transducers and receiving data signals that enable the condition of the cardiac valve to be determined.


Molecular Therapy | 2013

Ultrasound-targeted Microbubble Destruction-mediated Gene Delivery Into Canine Livers

Misty Noble; Christian S. Kuhr; Scott S. Graves; Keith R. Loeb; Samuel S. Sun; George W. Keilman; Kyle P. Morrison; Marla Paun; Rainer Storb; Carol H. Miao

Ultrasound (US) was applied to a targeted canine liver lobe simultaneously with injection of plasmid DNA (pDNA)/microbubble (MB) complexes into a portal vein (PV) segmental branch and occlusion of the inferior vena cava (IVC) to facilitate DNA uptake. By using a 1.1 MHz, 13 mm diameter transducer, a fivefold increase in luciferase activity was obtained at 3.3 MPa peak negative pressure (PNP) in the treated lobe. For more effective treatment of large tissue volumes in canines, a planar unfocused transducer with a large effective beam diameter (52 mm) was specifically constructed. Its apodized dual element configuration greatly reduced the near-field transaxial pressure variations, resulting in a remarkably uniform field of US exposure for the treated tissues. Together with a 15 kW capacity US amplifier, a 692-fold increase of gene expression was achieved at 2.7 MPa. Transaminase and histology analysis indicated minimal tissue damage. These experiments represent an important developmental step toward US-mediated gene delivery in large animals and clinics.


Journal of the Acoustical Society of America | 1994

Low-profile ultrasonic transducer incorporating static beam steering

Dipankar Ganguly; George W. Keilman

A cylindrical ultrasonic transducer (36) is disclosed. The transducer includes a cylindrical main element (38) provided with a plurality of ring-shaped secondary elements (40 and 42) that are triangular in cross section. By controlling the number, geometry, and construction of the secondary elements, substantially any desired ultrasonic emission pattern can be produced while maintaining a low overall transducer profile.

Collaboration


Dive into the George W. Keilman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shahram Vaezy

University of Washington

View shared research outputs
Top Co-Authors

Avatar

Roy W. Martin

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Proctor

University of Washington

View shared research outputs
Top Co-Authors

Avatar

Steve Carter

University of Washington

View shared research outputs
Top Co-Authors

Avatar

W. Scott Helton

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge